Trilogy Capital’s iShares US Equity Factor ETF LRGF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-102,724
Closed -$4.33M 170
2021
Q3
$4.33M Sell
102,724
-9,553
-9% -$418K 0.33% 54
2021
Q2
$4.89M Sell
112,277
-4,911
-4% -$208K 0.36% 52
2021
Q1
$4.76M Sell
117,188
-7,512
-6% -$295K 0.36% 53
2020
Q4
$4.7M Sell
124,700
-10,063
-7% -$358K 0.38% 51
2020
Q3
$4.47M Sell
134,763
-14,200
-10% -$466K 0.43% 48
2020
Q2
$4.81M Buy
148,963
+3,977
+3% +$118K 0.48% 52
2020
Q1
$4.24M Sell
144,986
-28,364
-16% -$914K 0.47% 50
2019
Q4
$5.97M Sell
173,350
-6,238
-3% -$207K 0.59% 44
2019
Q3
$5.66M Sell
179,588
-3,192
-2% -$101K 0.6% 46
2019
Q2
$5.88M Sell
182,780
-3,802
-2% -$119K 0.65% 41
2019
Q1
$5.79M Sell
186,582
-3,714
-2% -$112K 0.69% 40
2018
Q4
$5.3M Sell
190,296
-8,293
-4% -$255K 0.71% 32
2018
Q3
$6.68M Buy
198,589
+5,119
+3% +$171K 0.83% 29
2018
Q2
$6.18M Buy
193,470
+12,005
+7% +$387K 0.83% 29
2018
Q1
$5.72M Buy
181,465
+21,406
+13% +$692K 0.83% 29
2017
Q4
$5.09M Buy
+160,059
New +$4.99M 0.83% 28

Other funds holding LRGF

Trilogy Capital's LRGF Position: Q4 2021 in Review

Trilogy Capital sold out of iShares US Equity Factor ETF (LRGF) in Q4 2021, closing a stake of 102,724 shares — an estimated $4.33M sold.

Trilogy Capital first reported a position in LRGF in Q4 2017 and held it in 16 quarters. The position peaked at $6.68M in Q3 2018. 133 funds tracked by Wall St. Rank hold LRGF as of Q4 2021.

  • Trilogy Capital reported no remaining iShares US Equity Factor ETF position as of Q4 2021 after selling out during the quarter.
  • Trilogy Capital sold 102,724 iShares US Equity Factor ETF shares in Q4 2021, an estimated $4.33M.
  • Trilogy Capital first reported a position in iShares US Equity Factor ETF in Q4 2017 and held it in 16 quarters.
  • Trilogy Capital's iShares US Equity Factor ETF position peaked at $6.68M in Q3 2018.
  • 133 funds tracked by Wall St. Rank held iShares US Equity Factor ETF as of Q4 2021.

Based on Trilogy Capital's 13F filing for Q4 2021, filed 18 Jan 2022.